Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Depreciation & Amortization (IS): 2022-2025

Historic Depreciation & Amortization (IS) for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $113,360.

  • bioAffinity Technologies' Depreciation & Amortization (IS) fell 25.08% to $113,360 in Q3 2025 from the same period last year, while for Sep 2025 it was $534,809, marking a year-over-year decrease of 10.98%. This contributed to the annual value of $605,637 for FY2024, which is 142.65% up from last year.
  • bioAffinity Technologies' Depreciation & Amortization (IS) amounted to $113,360 in Q3 2025, which was up 0.12% from $113,229 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Depreciation & Amortization (IS) registered a high of $154,588 during Q1 2025, and its lowest value of $773 during Q3 2022.
  • For the 3-year period, bioAffinity Technologies' Depreciation & Amortization (IS) averaged around $112,401, with its median value being $148,787 (2023).
  • As far as peak fluctuations go, bioAffinity Technologies' Depreciation & Amortization (IS) skyrocketed by 7,347.48% in 2023, and later dropped by 25.08% in 2025.
  • Quarterly analysis of 4 years shows bioAffinity Technologies' Depreciation & Amortization (IS) stood at $7,330 in 2022, then surged by 1,929.84% to $148,787 in 2023, then increased by 3.26% to $153,632 in 2024, then dropped by 25.08% to $113,360 in 2025.
  • Its Depreciation & Amortization (IS) stands at $113,360 for Q3 2025, versus $113,229 for Q2 2025 and $154,588 for Q1 2025.